Journal of Inorganic and General Chemistry
ARTICLE
Zeitschrift für anorganische und allgemeine Chemie
[Pd(cod)(NH-acac)]PF6 (5): The compound was prepared in a similar 27 mmol). Crystals suitable for X-ray diffraction were obtained by
manner as described for 4, except AgPF6 (177 mg, 0.7 mmol) was used DCM / Et2O vapor diffusion. Yield 85 mg (55%). IR (KBr): ν˜ = νC=C
instead of AgBF4. Yield 32 mg (21%). IR (KBr): ν˜ = νN–H 3368,
νC=C 1582, νC=O 1699, νPd–O 692 and 474, νPd–[C=C] 557 cm–1.
1H NMR (600.28 MHz, CD2Cl2): δ = 2.097 (s, 3 H, CH3), 2.220 (s,
3 H, CH3), 2.698 (m, 4 H, CH2), 2.891 (m, 4 H, CH2), 5.239 (d, 1 H,
1518, νC=O 1566, νPt–O 659 and 474, νPt–[C=C] 522, νPt–N
1
548 cm–1. H NMR (600.28 MHz, CD2Cl2): δ = 1.806 (s, 3 H, CH3),
2.228 (s, 3 H, CH3), 2.392 (m, 4 H, CH2), 2.696 (m, 4 H, CH2), 4.712
(sep, 2 H, CH, J = 18.6 Hz, 8.4 Hz, 3 Hz), 5.619 (s, CH), 5.869 (sep,
CH, J = 2.4 Hz), 6.127 (m, 4 H, CH). 13C{1H} NMR (150.96 MHz, 2 H, CH, J = 15 Hz, 9 Hz, 2.4 Hz), 7.037 (d, 2 H, CH, J = 7.2 Hz),
CD2Cl2): δ = 24.93 (CH3), 25.15 (CH3), 28.97 (CH2), 31.05 (CH2), 7.34 (t, 1 H, CH, J = 7.8 Hz), 7.514 (t, 2 H, CH, J = 7.8 Hz). 13C{1H}
97.31 (CH), 110.76 (CH), 119.08 (CH), 166.36 (CN), 178.01 (CO).
NMR (150.96 MHz, CD2Cl2): δ = 24.9 (CH3), 25.43 (CH3), 28.03
(CH2), 30.77 (d, CH2, J = 25.6 Hz), 98.33 (CH), 101.45 (CH), 104.43
(CH), 146.91 (CN), 166.23 (CN), 177.35 (CO).
[Pt(cod)(NH-acac)]BF4 (6): An analogous method as described for 4
was used in the preparation of 6 replacing [Pd(cod)Cl2] with [Pt(cod)
Cl2] (100 mg, 27 mmol). Crystals suitable for X-ray diffraction were
obtained by DCM / Et2O vapor diffusion. Yield 55 mg (41%). IR
(KBr): ν˜ = νC=C 1539, νC=O 1587, νPt–O 664 and 470, νPt–[C=C]
[Pt(cod)(NPh-acac)]PF6 (11)[34]: The compound was prepared in a
similar manner as described for 10, replacing the AgBF4 with AgPF6
(135 mg, 27 mmol). Crystals suitable for X-ray diffraction were ob-
tained by DCM / Et2O vapor diffusion. Yield 132 mg (78%). IR
(KBr): ν˜ = νC=C 1519, νC=O 1563, νPt–O 658 and 473, νPt–[C=C]
1
521 cm–1. H NMR (600.28 MHz, CD2Cl2): δ = 2.136 (s, 3 H, CH3),
2.281 (s, 3 H, CH3), 2.508 (m, 4 H, CH2), 2.718 (m, 4 H, CH2), 5.428
(d, 1 H, CH, J = 2.4 Hz), 5.658 (dt, 4 H, CH, J = 3 Hz, 15.6 Hz),
9.212 (s, 1 H, NH). 13C{1H} NMR (150.96 MHz, CD2Cl2): δ = 25.55
(d, CH3, J = 7.5 Hz), 28.76 (CH3), 30.06 (CH2), 31.09 (CH2), 92.28
(CH), 100.01 (CH), 102.51 (CH), 166.48 (CN), 177.57 (CO).
1
557, νPt–N 525 cm–1. H NMR (600.28 MHz, CD2Cl2): δ = 1.804 (s,
2 H, CH3), 2.227 (s, 3 H, CH3), 2.387 (m, 4 H, CH2), 2.722 (m, 4 H,
CH2), 4.705 (sep, 2 H, CH, J = 20.4 Hz, 9 Hz, 2.4 Hz), 5.619 (s, 1 H,
CH), 5.866 (sep, 2 H, CH, J = 14.4 Hz, 9 Hz, 2.4 Hz), 7.03 (s, 2 H,
CH, J = 7.8 Hz), 7.34 (t, 1 H, CH, J = 7.2 Hz), 7.513 (t, 2 H, CH, J
= 7.8 Hz). 13C{1H} NMR (150.96 MHz, CD2Cl2): δ = 25.27 (CH3),
25.8 (CH3), 28.4 (CH2), 31.05 (CH2), 98.68 (CH), 101.83 (CH),
104.81 (CH), 125.51 (CH), 128.73 (CH), 130.25 (CH), 147.29 (CN),
166.62 (CN), 177.76 (CO).
[Pt(cod)(NH-acac)]PF6 (7): The compound was prepared in a similar
manner as described for 6, replacing the AgBF4 with AgPF6 (135 mg,
27 mmol). Crystals suitable for X-ray diffraction were obtained by
DCM / Et2O vapor diffusion. Yield 91 mg (60%). IR (KBr): ν˜ = νC=C
1539, νC=O 1587, νPt–O 664 and 471, νPt–[C=C] 557 cm–1. 1H NMR
(600.28 MHz, CD2Cl2): δ = 2.147 (2, 3 H, CH3), 2.269 (s, 3 H, CH3),
2.522 (m, 4 H, CH2), 2.725 (m, 4 H, CH2), 5.325 (d, 1 H, CH, J =
6.6 Hz), 5.627 (dt, 4 H, CH, J = 33 Hz, 57 Hz), 8.601 (s, 1 H, NH).
13C{1H} NMR (150.96 MHz, CD2Cl2): δ = 25.66 (d, CH3, J =
28.7 Hz), 28.76 (CH3), 29.95 (CH2), 31.04 (CH2), 92.21 (CH), 99.78
(d, CH, J = 83 Hz), 102.79 (CH), 166.51 (NH), 178.15 (CO).
Supporting Information (see footnote on the first page of this article):
Figures and Tables (21pp) are provided giving additional X-Ray re-
sults, Computed Orbitals as well as NMR and IR spectra.
Acknowledgements
[Pt(cod)(NMe-acac)]BF4 (8): Using the preparation method as de-
scribed for compound 6, ligand 1 was replaced with ligand 2 (31.9 μL,
27 mmol). Crystals suitable for X-ray diffraction were obtained by
DCM / Et2O vapor diffusion. Yield 96 mg (70%). IR (KBr): ν˜ = νC=C
1522, νC=O 1584, νPt–O 635 and 416, νPt–[C=C] 521, νPt–N
Financial assistance from the University of the Free State is gratefully
acknowledged. We thank Prof. Ola Wendt from the University of Lund,
Sweden for the use of their Oxford X-ray diffractometer. We also ex-
press our gratitude to SASOL, the South African National Research
Foundation (SA-NRF/THRIP), the Inkaba yeAfrica initiative, the UFS
Strategic Cluster Initiative (Materials and Nonosciences), the Swedish
International Development Co-operation Agency (SIDA), and the
Swiss NSF for financial support of this project. Part of this material is
based on work supported by the SA-NRF/ THRIP under grant number
GUN2068915 and GUN107802. Opinions, findings, conclusions or
recommendations expressed in this material are those of the authors
and do not necessarily reflect the views of the SA-NRF.
1
472 cm–1. H NMR (600.28 MHz, CD2Cl2): δ = 2.117 (s, 3 H, CH3),
2.228 (s, 3 H, CH3), 2.485 (m, 2 H, CH2), 2.607 (m, 2 H, CH2), 2.734
(m, 2 H, CH2), 2.890 (m, 2 H, CH2), 3.315 (t, 3 H, CH3, J = 12.6 Hz),
5.450 (s, 1 H, CH), 5.486 (sep 2 H, CH, J = 19.8 Hz, 7.8 Hz, 3 Hz),
5.791 (sep, 2 H, CH, J = 14.4 Hz, 9 Hz, 3 Hz). 13C{1H} NMR
(150.96 MHz, CD2Cl2): δ = 24.62 (CH3), 24.97 (CH3), 28.22 (CH2),
31.84 (CH2), 42.69 (CH), 97.32 (CH), 102.17 (CH), 104.83 (CH),
167.45 (CN), 174.94 (CO).
[Pt(cod)(NMe-acac)]PF6 (9): The compound was prepared in a sim-
ilar manner as described for 8, replacing the AgBF4 with AgPF6
(135 mg, 27 mmol). Crystals suitable for X-ray diffraction were ob-
tained by DCM / Et2O vapor diffusion. Yield 125 mg (82%). IR
(KBr): ν˜ = νC=C 1518, νC=O 1580, νPt–O 636 and 419, νPt–[C=C]
Keywords: Palladium; Platinum; Cyclooctadiene; X-ray crys-
tallography; Density functional calculations; Venus fly-trap
1
557, νPt–N 467 cm–1. H NMR (600.28 MHz, CD2Cl2): δ = 2.120 (s,
References
3 H, CH3), 2.224 (s, 3 H, CH3), 2.483 (m, 2 H, CH2), 2.602 (m, 2 H,
CH2), 2.731 (m, 2 H, CH2), 2.881 (m, 2 H, CH2), 3.299 (t, 3 H, CH3,
J = 12.6 Hz), 5.454 (s, 1 H, CH), 5.448 (sep, 2 H, CH, J = 22.2 Hz,
8.4 Hz, 3 Hz), 5.797 (sep, 2 H, CH, J = 14.4 Hz, 8.4 Hz, 3 Hz).
13C{1H} NMR (150.96 MHz, CD2Cl2): δ = 24.61 (CH3), 24.94 (CH3),
28.2 (CH2), 31.21 (CH2), 42.59 (CH3), 97.16 (CH), 102.17 (CH),
104.89 (CH), 167.46 (CN), 175.01 (CO).
[1] C. A. Buehler, D. E. Pearson, Survey of Organic Synthesis, vol 1,
Wiley-Interscience, New York, 1970.
[2] G. Oenbrink, T. Schiffer, Cyclododecatriene, Cyclooctadiene, and
4-Vinylcyclohexene, in Ullmann’s Encyclopedia of Industrial
Chemistry, Evonik Degussa GmbH, Marl, Germany, 2009.
[3] a) A. Roodt, S. Otto, G. Steyl, Coord. Chem. Rev. 2003, 245,
125–142; b) A. Brink, H. G. Visser, A. Roodt, G. Steyl, Dalton
Trans. 2010, 39, 5572–5578; c) M. T. Johnson, R. Johansson,
M. V. Kondrashov, G. Steyl, M. S. G. Ahlquist, A. Roodt, O. F.
Wendt, Organometallics 2010, 29, 3521–3529.
[Pt(cod)(NPh-acac)]BF4 (10): Using the preparation method as de-
scribed for compound 6, ligand 2 was replaced with ligand 3 (47 mg,
Z. Anorg. Allg. Chem. 2018, 763–774
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim